Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Astra Merck launches Lexxel in U.S.

March 14, 1997

Beth Israel evaluates bFGF for coronary artery disease

March 14, 1997

Selective cGMP-PDE inhibitors claimed by Otsuka

March 14, 1997

German introduction for spirapril

March 12, 1997

Atorvastatin approved in Canada

March 11, 1997

Biogen and CV Therapeutics codevelop cardiovascular therapy

March 11, 1997

Na+/K+-exchange inhibitors from Merck KGaA

March 11, 1997

Merck KGaA's new ET antagonists

March 11, 1997

Prostaglandin derivatives from Ono

March 11, 1997

Potent, long-acting ETA antagonist described by Zeneca

March 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...